Lupus erythematosus (LE) is a chronic, autoimmune, multisystem disease that displays
many diverse symptoms in which localized cutaneous LE (CLE) is on one end of the …

Pityriasis rosea is self-limiting, usually lasting 1–3 months. Treatment may be considered in
certain cases, although there is a paucity of medical studies supporting any definitive …

Systemic lupus erythematosus (SLE) is a chronic, multisystem, inflammatory autoimmune
disease characterized by relapses (commonly called “flares”) and remission. Many organs …

A 58-year-old woman presented with a history of subacute cutaneous lupus erythematosus
(SCLE) for the past 6 years, associated with photosensitivity, arthralgia, and fatigue. There …

Collagen vascular diseases such as lupus erythematosus (LE) and dermatomyositis (DM)
occur 2 to 3 times more often among patients with skin of color, and symptoms develop at …

Background Discoid lupus erythematosus (DLE) is characterized by scarring lesions that
develop and perpetuate fibrotic lesions. These are not observed in subacute cutaneous …

We compared the presence of diverse cytokines and regulatory T and B cells in skin
biopsies of discoid lupus erythematosus (DLE) and subacute cutaneous lupus …

Fibroblasts are stromal cells known to regulate local immune responses important for wound
healing and scar formation; however, the cellular mechanisms driving damage and scarring …

SLE is a highly variable systemic autoimmune disease. Its immunopathological effector
phase is partly understood. However, the background of its variability is not. SLE …

Background Cutaneous lupus erythematosus (CLE) includes a broad range of dermatologic
manifestations. Periorbital involvement, however, is a relatively rare clinical presentation of …